Per Morten Sandset

Long-term outcome after additional catheter-directed thrombolysis versus standard treatment for acute iliofemoral deep vein thrombosis (the CaVenT study): a randomised controlled trial

Tone Enden, Ylva Haig, Nils‐Einar Kløw et al. · The Lancet · 2011 · 968 citations

Thrombosis, Pulmonary Embolism, Cardiovascular Disease +11

Pharmacodynamics, pharmacokinetics, and safety of the oral reversible P2Y12 antagonist AZD6140 with aspirin in patients with atherosclerosis: a double-blind comparison to clopidogrel with aspirin

Steen Husted, Håkan Emanuelsson, Stan Heptinstall et al. · European Heart Journal · 2006 · 738 citations · Full text

Editor's Choice – European Society for Vascular Surgery (ESVS) 2021 Clinical Practice Guidelines on the Management of Venous Thrombosis

Stavros K. Kakkos, Manjit Gohel, Rupert Bauersachs et al. · European Journal of Vascular and Endovascular Surgery · 2020 · 657 citations · Full text

Thrombosis, Venous Disease, Venous Thrombosis +9

Incidence and risk patterns of venous thromboembolism in pregnancy and puerperium—a register-based case-control study

Anne Flem Jacobsen, Finn Egil Skjeldestad, Per Morten Sandset · American Journal of Obstetrics and Gynecology · 2007 · 468 citations

Thrombosis, Venous Thrombosis, Cardiovascular Disease +10

Post-thrombotic syndrome after catheter-directed thrombolysis for deep vein thrombosis (CaVenT): 5-year follow-up results of an open-label, randomised controlled trial

Ylva Haig, Tone Enden, Ole Jørgen Grøtta et al. · The Lancet Haematology · 2016 · 435 citations

Thrombosis, Pulmonary Embolism, Catheter-directed Thrombolysis +8